Lumabs

1 known investors

LUMABS BV develops RAPPID, a one-step mix-and-measure antibody detection technology for rapid, sensitive quantification of antibodies or antigens such as therapeutic drugs directly in biological samples including blood. It targets clinical diagnostics as an alternative to conventional immunoassays like ELISA, SPR, and RIA to support personalized healthcare decisions.

BiotechMedical Devices